GURUFOCUS.COM » STOCK LIST » Healthcare » Medical Devices & Instruments » Bruker Corp (FRA:BKD) » Definitions » Cyclically Adjusted Revenue per Share

Bruker (FRA:BKD) Cyclically Adjusted Revenue per Share : €14.61 (As of Mar. 2024)


View and export this data going back to . Start your Free Trial

What is Bruker Cyclically Adjusted Revenue per Share?

E10 is a concept invented by Prof. Robert Shiller, who uses E10 for his Shiller PE Ratio calculation. E10 is the average of the inflation adjusted earnings of a company over the past 10 years. The similar calculation is applied by GuruFocus to calculate the Cyclically Adjusted Revenue per Share and the Cyclically Adjusted PS Ratio. The Cyclically Adjusted Revenue per Share is the average of the inflation adjusted Revenue per Share of a company over the past 10 years.

Bruker's adjusted revenue per share for the three months ended in Mar. 2024 was €4.551. Add all the adjusted revenue per share for the past 10 years together and divide the count will get our Cyclically Adjusted Revenue per Share, which is €14.61 for the trailing ten years ended in Mar. 2024.

During the past 12 months, Bruker's average Cyclically Adjusted Revenue Growth Rate was 7.50% per year. During the past 3 years, the average Cyclically Adjusted Revenue Growth Rate was 8.90% per year. During the past 5 years, the average Cyclically Adjusted Revenue Growth Rate was 7.80% per year. During the past 10 years, the average Cyclically Adjusted Revenue Growth Rate was 7.20% per year. Please click Growth Rate Calculation Example (GuruFocus) to see how GuruFocus calculates Wal-Mart Stores Inc (WMT)'s revenue growth rate. You can apply the same method to get the Cyclically Adjusted Revenue Growth Rate using Cyclically Adjusted Revenue per Share data.

During the past 13 years, the highest 3-Year average Cyclically Adjusted Revenue Growth Rate of Bruker was 14.10% per year. The lowest was 5.90% per year. And the median was 7.95% per year.

As of today (2024-05-22), Bruker's current stock price is €69.94. Bruker's Cyclically Adjusted Revenue per Share for the quarter that ended in Mar. 2024 was €14.61. Bruker's Cyclically Adjusted PS Ratio of today is 4.79.

During the past 13 years, the highest Cyclically Adjusted PS Ratio of Bruker was 7.22. The lowest was 1.94. And the median was 3.28.


Bruker Cyclically Adjusted Revenue per Share Historical Data

The historical data trend for Bruker's Cyclically Adjusted Revenue per Share can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Bruker Cyclically Adjusted Revenue per Share Chart

Bruker Annual Data
Trend Dec14 Dec15 Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23
Cyclically Adjusted Revenue per Share
Get a 7-Day Free Trial Premium Member Only Premium Member Only 10.19 9.58 11.54 13.55 13.96

Bruker Quarterly Data
Jun19 Sep19 Dec19 Mar20 Jun20 Sep20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24
Cyclically Adjusted Revenue per Share Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 13.48 13.62 14.51 13.96 14.61

Competitive Comparison of Bruker's Cyclically Adjusted Revenue per Share

For the Medical Devices subindustry, Bruker's Cyclically Adjusted PS Ratio, along with its competitors' market caps and Cyclically Adjusted PS Ratio data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Bruker's Cyclically Adjusted PS Ratio Distribution in the Medical Devices & Instruments Industry

For the Medical Devices & Instruments industry and Healthcare sector, Bruker's Cyclically Adjusted PS Ratio distribution charts can be found below:

* The bar in red indicates where Bruker's Cyclically Adjusted PS Ratio falls into.



Bruker Cyclically Adjusted Revenue per Share Calculation

E10 is a concept invented by Prof. Robert Shiller, who uses E10 for his Shiller PE Ratio calculation. E10 is the average of the inflation adjusted earnings of a company over the past 10 years. The similar calculation is applied by GuruFocus to calculate the Cyclically Adjusted Revenue per Share and the Cyclically Adjusted PS Ratio. The Cyclically Adjusted Revenue per Share is the average of the inflation adjusted Revenue per Share of a company over the past 10 years.

What is Cyclically Adjusted Revenue per Share? How do we calculate Cyclically Adjusted Revenue per Share?

Cyclically Adjusted Revenue per Share is the average of the inflation adjusted Revenue per Share of a company over the past 10 years. Let's use an example to explain.

If we want to calculate the Cyclically Adjusted Revenue per Share of Wal-Mart (WMT) for Dec. 31, 2010, we need to have the inflation data and the revenue per share from 2001 through 2010.

We adjusted the 2001 revenue per share data with the total inflation from 2001 through 2010 to the equivalent revenue in 2010. If the total inflation from 2001 to 2010 is 40%, and Wal-Mart's revenue is $1 a share in 2001, then the 2001's equivalent revenue in 2010 is $1.4 a share. If Wal-Mart's revenue is $1 again in 2002, and the total inflation from 2002 through 2010 is 35%, then the equivalent 2002 revenue in 2010 is $1.35. So on and so forth, you get the equivalent revenue per share of past 10 years. Then you add them together and divided the sum by the count to get Cyclically Adjusted Revenue per Share.

Please note that we use the CPI data of the country/region where the company is headquartered. If the CPI data for that country/region is not available, then we will use the CPI data of the United States as default.

For example, Bruker's adjusted Revenue per Share data for the three months ended in Mar. 2024 was:

Adj_RevenuePerShare= Revenue per Share /CPI of Mar. 2024 (Change)*Current CPI (Mar. 2024)
=4.551/131.7762*131.7762
=4.551

Current CPI (Mar. 2024) = 131.7762.

Bruker Quarterly Data

Revenue per Share CPI Adj_RevenuePerShare
201406 1.986 100.560 2.603
201409 1.921 100.428 2.521
201412 2.431 99.070 3.234
201503 1.925 99.621 2.546
201506 2.079 100.684 2.721
201509 2.092 100.392 2.746
201512 2.596 99.792 3.428
201603 2.052 100.470 2.691
201606 2.037 101.688 2.640
201609 2.173 101.861 2.811
201612 2.774 101.863 3.589
201703 2.242 102.862 2.872
201706 2.302 103.349 2.935
201709 2.303 104.136 2.914
201712 2.861 104.011 3.625
201803 2.230 105.290 2.791
201806 2.419 106.317 2.998
201809 2.541 106.507 3.144
201812 3.096 105.998 3.849
201903 2.586 107.251 3.177
201906 2.753 108.070 3.357
201909 3.041 108.329 3.699
201912 3.474 108.420 4.222
202003 2.469 108.902 2.988
202006 2.437 108.767 2.953
202009 2.814 109.815 3.377
202012 3.349 109.897 4.016
202103 3.041 111.754 3.586
202106 3.099 114.631 3.563
202109 3.387 115.734 3.856
202112 3.964 117.630 4.441
202203 3.568 121.301 3.876
202206 3.716 125.017 3.917
202209 4.342 125.227 4.569
202212 4.522 125.222 4.759
202303 4.337 127.348 4.488
202306 4.261 128.729 4.362
202309 4.725 129.860 4.795
202312 5.356 129.419 5.454
202403 4.551 131.776 4.551

Add all the adjusted revenue per share together and divide 10 will get our Cyclically Adjusted Revenue per Share.


Bruker  (FRA:BKD) Cyclically Adjusted Revenue per Share Explanation

If a company grows much fast than inflation, Cyclically Adjusted Revenue per Share may underestimate the company's revenue. Cyclically Adjusted PS Ratio can seem to be too high even the actual PS Ratio is low.

For the Cyclically Adjusted PS Ratio, the revenue per share of the past 10 years are inflation-adjusted and averaged. The result is used for P/S calculation. Since it looks at the average over the last 10 years, the Cyclically Adjusted PS Ratio is also called CAPS Ratio.

The Shiller PE Ratio was first used by professor Robert Shiller. He uses E10 for his Shiller PE Ratio calculation. E10 is the average of the inflation adjusted earnings per share of a company over the past 10 years. The similar calculation is applied by GuruFocus to calculate the Cyclically Adjusted PS Ratio. The Cyclically Adjusted Revenue per Share is the average of the inflation adjusted revenue per share of a company over the past 10 years.

Bruker's Cyclically Adjusted PS Ratio of today is calculated as

Cyclically Adjusted PS Ratio=Share Price/Cyclically Adjusted Revenue per Share
=69.94/14.61
=4.79

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

During the past 13 years, the highest Cyclically Adjusted PS Ratio of Bruker was 7.22. The lowest was 1.94. And the median was 3.28.


Be Aware

Cyclically Adjusted PS Ratio works better for cyclical companies. It gives you a better idea on the company's real revenue value.


Bruker Cyclically Adjusted Revenue per Share Related Terms

Thank you for viewing the detailed overview of Bruker's Cyclically Adjusted Revenue per Share provided by GuruFocus.com. Please click on the following links to see related term pages.


Bruker (FRA:BKD) Business Description

Industry
Traded in Other Exchanges
Address
40 Manning Road, Billerica, MA, USA, 01821
Bruker Corp manufactures scientific instruments and diagnostic tests for customers in the life sciences, pharmaceutical, and biotechnology industries. It operates in four operating segments: Bruker Scientific Instruments (BSI) BioSpin, BSI CALID, BSI Nano and Bruker Energy and Supercon Technologies (BEST). The company generates maximum revenue from the BSI CALID segment. Geographically, it derives a majority of its revenue from Europe.